HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Streptococcus suis meningitis: the newest serious infectious disease.

AbstractThe authors report 41 patients with meningitis caused by Streptococcus suis. The clinical feature of the meningitis is characteristic with severe sensorineural hearing loss, developing early during the course of meningitis. These patients were cured with high doses of penicillin or third generation cephalosporins but the deafness remained permanent. The mechanism of the cochlear and vestibular damage is uncertain; presumably, it is caused by some oto-toxins from bacteria. The disease may become an occupational risk of pork handlers and a public health problem in Thailand.
AuthorsSiwarith Rusmeechan, Paoworamol Sribusara (Affiliation: Department of Medicine, Buddhachinaraj Hospital, Phitsanuloke, Thailand. siwasith at hotmail.com)
JournalJournal of the Medical Association of Thailand = Chotmaihet thangphaet (J Med Assoc Thai) Vol. 91 Issue 5 Pg. 654-8 (May 2008) ISSN: 0125-2208 [Print] Thailand
PMID18672627 (Publication Type: Journal Article)
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Epidemiologic Studies
  • Female
  • Food Contamination
  • Food Handling
  • Health Status Indicators
  • Hearing Loss, Sensorineural (etiology)
  • Humans
  • Incidence
  • Male
  • Meningitis, Bacterial (drug therapy, epidemiology, etiology, microbiology)
  • Middle Aged
  • Risk Factors
  • Streptococcal Infections (complications, drug therapy, epidemiology, microbiology)
  • Streptococcus suis (isolation & purification)
  • Thailand (epidemiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Research Interface PRO additionally includes drill-down to evidence, articles by author, export to Excel, FDA Link and mobile subscription:
1 year subscription, $45.00 USD